BioStem Technologies BSEM
NASDAQ BSEM
$1.47 +0.43 (+41.35%)
At close: Nov 11, 2026 · 4:00 PM EST

BioStem Technologies (BSEM) Amortization of Deferred Charges (2025 - 2026)

Analysis

BioStem Technologies (BSEM) Amortization of Deferred Charges (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 266.22 Bn 242.86 Bn 5.13 Bn
2 Abbott Laboratories 191.31 Bn 165.77 Bn 7.39 Bn
3 Danaher 166.16 Bn 145.82 Bn 3.84 Bn
4 Intuitive Surgical 155.98 Bn 136.40 Bn 2.08 Bn
5 Medtronic 130.05 Bn 96.18 Bn 6.34 Bn
6 Stryker 123.40 Bn 109.59 Bn 4.25 Bn
7 Boston Scientific 64.81 Bn 60.48 Bn 3.43 Bn
8 Edwards Lifesciences 59.87 Bn 43.18 Bn 1.35 Bn
9 Medline 53.84 Bn 50.96 Bn 1.93 Bn
10 BioStem Technologies 18.55 Mn -54.49 Mn 4.84 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 54,848.00
Mar 31, 2026 51,868.00
Jun 30, 2025 39,497.00
Mar 31, 2025 24,110.00
API Access

BioStem Technologies Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=BSEM&period=max&api_key=YOUR_API_KEY